For those new to social media, Nathalie Bourré, a pharmaceutical marketing and social media consultant, gave a quick introduction to the arena. This was followed by a presentations by Patrick Massad, the Chief Review Officer at the PAAB, and Henry Anderson, who manages interactive marketing in the Americas for Novartis Consumer Health. Afterward, participants put their knowledge to the test as an expert panel weighed in on the feasibility, legality, and review requirements of several case studies involving different aspects of social media. Members of the panel included Ray Chepesiuk from the PAAB, Ann Sztuke-Fournier from Health Canada, and three industry representatives: Nathalie Bourré, Henry Anderson, and Christian Roy (Pfizer Canada; Montreal session) or Pat Forsythe (Allergan Canada; Toronto session).
While their opinions didn't always agree 100%, a few bits of consensus were clear:
- The same rules that govern print media apply to social media and web. For example, branded promotion geared towards physicians must be gated to avoid consumer access.
- Just like print media, intent of dissemination and control of content are key. Are you providing unbiased information or promoting a product?
- If you create the discussion environment, you are responsible for monitoring it. Moderate discussions to remove off-label and promotional comments by participants. Be clear and pro-active about your posting and moderation policies.
- Don't use social media for the sake of using social media. Make sure it fits into your marketing strategy. Marketing principles have not changed with the rise of social media, only the medium.
A few participants, myself included, live-tweeted the event. To find out what we thought, simply seach #paab on Twitter.